The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer.

MLA

Niwa, Naoya, et al. “The Clinical Implication of Gamma Globulin Levels in Patients with Nonmuscle-Invasive Bladder Cancer.” Urologic Oncology, vol. 37, no. 4, Apr. 2019, p. 291.e1-291.e7. EBSCOhost, https://doi.org/10.1016/j.urolonc.2018.12.026.

APA

Niwa, N., Matsumoto, K., & Ide, H. (2019). The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer. Urologic Oncology, 37(4), 291.e1-291.e7. https://doi.org/10.1016/j.urolonc.2018.12.026

Chicago

Niwa, Naoya, Kazuhiro Matsumoto, and Hiroki Ide. 2019. “The Clinical Implication of Gamma Globulin Levels in Patients with Nonmuscle-Invasive Bladder Cancer.” Urologic Oncology 37 (4): 291.e1-291.e7. doi:10.1016/j.urolonc.2018.12.026.